BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32281421)

  • 21. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in
    Colini Baldeschi A; Pittaluga E; Andreola F; Rossi S; Cozzolino M; Nicotera G; Sferrazza G; Pierimarchi P; Serafino A
    Front Aging Neurosci; 2018; 10():20. PubMed ID: 29449807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming energetic metabolism in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt/β-catenin signaling pathway contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury and is possibly related to the transforming growth factorβ1/Smad3 signaling pathway.
    Zhang G; Ge M; Han Z; Wang S; Yin J; Peng L; Xu F; Zhang Q; Dai Z; Xie L; Li Y; Si J; Ma K
    Biomed Pharmacother; 2019 Feb; 110():420-430. PubMed ID: 30530044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
    Nishiya N
    Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
    Prosperi JR; Goss KH
    Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
    Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
    J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt signaling: role in LTP, neural networks and memory.
    Oliva CA; Vargas JY; Inestrosa NC
    Ageing Res Rev; 2013 Jun; 12(3):786-800. PubMed ID: 23665425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.
    Berwick DC; Javaheri B; Wetzel A; Hopkinson M; Nixon-Abell J; Grannò S; Pitsillides AA; Harvey K
    Mol Neurodegener; 2017 Jan; 12(1):9. PubMed ID: 28103901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway.
    Salašová A; Yokota C; Potěšil D; Zdráhal Z; Bryja V; Arenas E
    Mol Neurodegener; 2017 Jul; 12(1):54. PubMed ID: 28697798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Wnt Signaling Builds the Brain: Bridging Development and Disease.
    Noelanders R; Vleminckx K
    Neuroscientist; 2017 Jun; 23(3):314-329. PubMed ID: 27624848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remarkable impairment of Wnt/β-catenin signaling in the brains of the mice infected with scrapie agents.
    Sun J; Wang H; Chen LN; Wang J; Lv Y; Yang XD; Zhang BY; Tian C; Shi Q; Dong XP
    J Neurochem; 2016 Feb; 136(4):731-740. PubMed ID: 26526056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling.
    Giovannini D; Andreola F; Spitalieri P; Krasnowska EK; Colini Baldeschi A; Rossi S; Sangiuolo F; Cozzolino M; Serafino A
    Cell Death Discov; 2021 Nov; 7(1):330. PubMed ID: 34725335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt/β-catenin signaling in Alzheimer's disease.
    De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
    CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
    Verma MK; Goel R; Krishnadas N; Nemmani KVS
    Expert Opin Ther Targets; 2018 Jul; 22(7):615-628. PubMed ID: 29911915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt signalling pathway and tau phosphorylation: A comprehensive study on known connections.
    Hadi F; Akrami H; Shahpasand K; Fattahi MR
    Cell Biochem Funct; 2020 Aug; 38(6):686-694. PubMed ID: 32232872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-carnitine contributes to enhancement of neurogenesis from mesenchymal stem cells through Wnt/β-catenin and PKA pathway.
    Fathi E; Farahzadi R; Charoudeh HN
    Exp Biol Med (Maywood); 2017 Mar; 242(5):482-486. PubMed ID: 28056548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis.
    Zhou Y; Wang T; Hamilton JL; Chen D
    Curr Rheumatol Rep; 2017 Sep; 19(9):53. PubMed ID: 28752488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
    Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
    Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.